Nutrasource expands with on-site clinic to support trials

Nutrasource-expands-with-on-site-clinic-to-support-trials.jpg
Nutrasource says its expanded facility includes extensive laboratory facilities for real time sample preparation and analysis. Nutrasource photo.

Canadian contract research organization Nutrasource has completed an expansion to its on-site clinic that it says will enable the company to conduct a wide variety of trials.

The new clinic, which is located in Guelph, builds upon a 2019 expansion.  It includes an overnight facility for trials that require more close monitoring of subjects. In addition, the new facility has a full kitchen that can put together specialized meals for metabolic trials and it includes a full suite of diagnostic exercise equipment for sports nutrition studies. The new facility also includes a complete lab for the processing and analysis of stool, blood, urine and tissue samples.

“This infrastructure growth has more than doubled our capacity and adds clinical tools unique to the nutritional CRO space,  said Nutrasource CEO William Rowe.

Rowe said the company’s new capabilities will help manage trials in this challenging atmosphere where face-to-face interaction has been limited.  He gave as an example a recent trial the company embarked upon that has successfully screened, enrolled, and randomized 270 participants in 47 US states within a three month time frame.  The company says the study, which includes collection of stool samples and questionnaires, continues to display high participant interest and engagement, all while maintaining a low participant attrition rate. 

Nutrasource now has more than 100 employees and boasts of global client list of more than 2,000.  In addition to running trials, the company does product testing for dietary supplements, foods, pharmaceuticals and medical devices.  The company also consults on regulatory affairs and assists clients in market entry in North America, the EU and the Asia Pacific region.  The company claims to have successfully completed more than 750 clinical trials.